Recalls / Active ingredient / Quetiapine Fumarate
Quetiapine Fumarate
5 FDA drug recalls involving the active ingredient “Quetiapine Fumarate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2020-02-27 | Class III | Quetiapine Fumarate Extended-Release Tablets, 200 mg, 100 tablets per unit dose carton, Rx only, Manufactured | The Harvard Drug Group |
| 2020-02-27 | Class III | Quetiapine Fumarate Extended-Release Tablets, 300 mg, 100 tablets per unit dose carton, Rx only, Manufactured | The Harvard Drug Group |
| 2020-02-27 | Class III | Quetiapine Fumarate Extended-Release Tablets, 50 mg, 100 tablets per unit dose carton, Rx only, Manufactured b | The Harvard Drug Group |
| 2020-02-27 | Class III | Quetiapine Fumarate Extended-Release Tablets, 150 mg, 100 tablets per unit dose carton, Rx only, Manufactured | The Harvard Drug Group |
| 2018-11-14 | Class II | Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai | Ascend Laboratories LLC |